Purchase Order 75N95020P00165
Award Date 4/10/20
Potential Completion Date 10/9/21
Potential Value $13K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
China
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Wuxi Apptec (Hongkong) LIMITED, a global provider of research and development services to the pharmaceutical and healthcare industry. The $17,750.00 firm fixed price purchase order is for the synthesis of six analogues of OSMI-4A, with a period of performance from August 28, 2020 to November 6, 2020. The...
- This is a $115,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED, a global contract research and development organization. The contract is for the provision of chemical compounds, small molecule compound libraries, analogues, and other materials to support NIDA's research activities, which may include testing anti-cancer drug candidates, lowering...
- This is a firm-fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED for the acquisition of 15 grams of PT-2977 (CAS: 1672668-24-4) with a chemical purity exceeding 95% and enantiopurity exceeding 95%. The contract has a ceiling value of $24,800.00 and a completion date of July 8, 2020. This award is not associated with any set-aside program. Wuxi...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to Wuxi Apptec (Hongkong) LIMITED, a for-profit limited liability company. The contract has a ceiling value of $4,800.00 and a completion date of February 28, 2019. The contract is for the synthesis of a custom drug called KD025. There is no set-aside designation for this award. Through prior prime contract awards, Wuxi Apptec (Hongkong)...
- The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) awarded a $471,850 firm fixed price purchase order to Medkoo Biosciences for a small molecule library. The library will contain 52 specific compounds requested in the solicitation to support NCATS' Early Translation Branch pre-clinical screening and research efforts. The library must be delivered to the NIH location in Bethesda, Maryland within one year of the September 2022 award date....
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Wuxi Apptec (Hongkong) LIMITED. The contract, valued at $128,000.00, is for the synthesis of 2R,6R-hydroxynorketamine hydrochloride. The contract is a firm fixed price purchase order with a completion date of January 21, 2017. The contract does not have a set-aside designation. Wuxi Apptec (Hongkong) LIMITED is a global contract research and development...
- <p>This is a $92,334.95 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Apexbio Technology, LLC, a small business, for the delivery of 2,234 compounds of 5mg size. The contract has a completion date of July 20, 2015. This contract award is not associated with a larger contract vehicle.</p>
- This federal contract award is for the delivery of a small molecules screening library to the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services. The $23,095 firm fixed-price purchase order was awarded to Medchemexpress LLC, a foreign-owned, minority-owned, and self-certified small disadvantaged business based in New Jersey. The contract does not have a set-aside designation. The award is to...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $29,820 firm fixed price purchase order to Medchemexpress LLC to deliver forty-four bioactive compounds for replenishment and expansion of the Mechanism Interrogation PlatE 6.0 screening library. The compounds will support the Center's high-capacity robotic platform used to screen drug combinations and further its chemogenomic screening capabilities. Delivery...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a firm fixed price purchase order contract valued at $10,440.00 to Pharmaron, Inc., a minority-owned, for-profit organization based in China. The contract is for a pharmacokinetic study of the drugs tamoxifen and neurotinib, with a period of performance running through October 9, 2023. Pharmaron has received over 30 prior prime contract awards...